Literature DB >> 21900228

'Cone dystrophy with supranormal rod response' in children.

Arif O Khan1, May Alrashed, Fowzan S Alkuraya.   

Abstract

AIM: To describe the initial clinical presentation of children with 'cone dystrophy with supranormal rod response,' a distinct retinal disorder from recessive KCNV2 mutations.
METHODS: Retrospective case series.
RESULTS: Nine children (seven families) initially examined from 2 to 8 years of age were identified. Three had a similar initial presentation of abnormal head position with head shaking and nystagmus, while the other six presented with either infantile nystagmus (without abnormal head position or head shaking), suspected congenital glaucoma (with associated nystagmus), intermittent exotropia, V-pattern esotropia, comitant esotropia or difficulty with near vision only (reading). Only two children had clinically evident retinal changes (macular discoloration), and only two had a myopic cycloplegic refraction (the child with infantile nystagmus and the glaucoma suspect who actually had megalocornea). In addition to cone dystrophy, ERGs showed delayed scotopic responses with supranormal (six), high normal (two) or normal (one) scotopic b-wave responses to bright flash. Only one ERG (with a supranormal response) did not show a broad a-wave trough response to scotopic flash. For all patients, KCNV2 sequencing revealed one of three homozygous recessive mutations (one previously reported (p.E143X), two novel (p.Y53X, p.E80D)). The three children who presented with an abnormal head position, head shaking and nystagmus and the child who presented with infantile nystagmus had several years' follow-up, during which these findings resolved (two) or decreased (two).
CONCLUSIONS: Initial clinical presentation varied, the most common presentation being abnormal head position, head shaking and nystagmus that improved with time. ERG findings are characteristic and specific for KCNV2 mutations but do not necessarily include a scotopic b-wave flash response that is supranormal under standard ERG conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900228     DOI: 10.1136/bjophthalmol-2011-300271

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Two-color pupillometry in KCNV2 retinopathy.

Authors:  Frederick T Collison; Jason C Park; Gerald A Fishman; Edwin M Stone; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2019-03-29       Impact factor: 2.379

2.  Phenotypic characteristics including in vivo cone photoreceptor mosaic in KCNV2-related "cone dystrophy with supernormal rod electroretinogram".

Authors:  Ajoy Vincent; Tom Wright; Yaiza Garcia-Sanchez; Marsha Kisilak; Melanie Campbell; Carol Westall; Elise Héon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-30       Impact factor: 4.799

3.  Functional analysis of missense mutations in Kv8.2 causing cone dystrophy with supernormal rod electroretinogram.

Authors:  Katie E Smith; Susan E Wilkie; Joseph T Tebbs-Warner; Bradley J Jarvis; Linn Gallasch; Martin Stocker; David M Hunt
Journal:  J Biol Chem       Date:  2012-10-31       Impact factor: 5.157

4.  KCNV2-Associated Retinopathy: Genetics, Electrophysiology, and Clinical Course-KCNV2 Study Group Report 1.

Authors:  Michalis Georgiou; Anthony G Robson; Kaoru Fujinami; Shaun M Leo; Ajoy Vincent; Fadi Nasser; Thales Antônio Cabral De Guimarães; Samer Khateb; Nikolas Pontikos; Yu Fujinami-Yokokawa; Xiao Liu; Kazushige Tsunoda; Takaaki Hayashi; Mauricio E Vargas; Alberta A H J Thiadens; Emanuel R de Carvalho; Xuan-Thanh-An Nguyen; Gavin Arno; Omar A Mahroo; Maria Inmaculada Martin-Merida; Belen Jimenez-Rolando; Gema Gordo; Ester Carreño; Ayuso Carmen; Dror Sharon; Susanne Kohl; Rachel M Huckfeldt; Bernd Wissinger; Camiel J F Boon; Eyal Banin; Mark E Pennesi; Arif O Khan; Andrew R Webster; Eberhart Zrenner; Elise Héon; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2020-12-11       Impact factor: 5.258

5.  Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants.

Authors:  Kaoru Fujinami; Kazushige Tsunoda; Natsuko Nakamura; Yu Kato; Toru Noda; Kei Shinoda; Kaoru Tomita; Tetsuhisa Hatase; Tomoaki Usui; Masakazu Akahori; Takeshi Itabashi; Takeshi Iwata; Yoko Ozawa; Kazuo Tsubota; Yozo Miyake
Journal:  Mol Vis       Date:  2013-07-20       Impact factor: 2.367

Review 6.  KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy.

Authors:  Thales A C De Guimaraes; Michalis Georgiou; Anthony G Robson; Michel Michaelides
Journal:  Ophthalmic Genet       Date:  2020-05-22       Impact factor: 1.803

7.  Compound heterozygous KCNV2 variants contribute to cone dystrophy with supernormal rod responses in a Chinese family.

Authors:  Man Liu; Yingchuan Zhu; Lian Huang; Wenhao Jiang; Na Wu; Yue Song; Yilu Lu; Yongxin Ma
Journal:  Mol Genet Genomic Med       Date:  2021-09-18       Impact factor: 2.183

8.  Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes.

Authors:  Leen Abu-Safieh; May Alrashed; Shamsa Anazi; Hisham Alkuraya; Arif O Khan; Mohammed Al-Owain; Jawahir Al-Zahrani; Lama Al-Abdi; Mais Hashem; Salwa Al-Tarimi; Mohammed-Adeeb Sebai; Ahmed Shamia; Mohamed D Ray-Zack; Malik Nassan; Zuhair N Al-Hassnan; Zuhair Rahbeeni; Saad Waheeb; Abdullah Alkharashi; Emad Abboud; Selwa A F Al-Hazzaa; Fowzan S Alkuraya
Journal:  Genome Res       Date:  2012-10-26       Impact factor: 9.043

9.  Pseudodominance in two families with KCNV2 related retinopathy.

Authors:  Gulunay Kiray; Micah Rapata; Dianne Sharp; Andrea L Vincent
Journal:  Am J Ophthalmol Case Rep       Date:  2020-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.